INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Showing studies that examined broccoli. Clear

People assigned to a diet, food or program and measured.

4 studies

2018 / Randomized crossover trial

Eating broccoli with mashed potato reduced initial postprandial glucose and insulin responses.

In a randomized crossover trial with 13 healthy adults, adding two portions of cooked broccoli to mashed potato led to lower early postprandial blood glucose and insulin surges than potato alone. The broccoli-potato combination reduced peak glucose, incremental peak, and 30-minute incremental area under the curve for both markers. However, adding isolated broccoli fibre or cellulose did not alter post-meal curves compared with potato eaten by itself.

Ballance S, Knutsen SH, Fosvold ØW, et al. Eur J Nutr, 2018. PMID 27655525

2014 / Randomized clinical trial

Broccoli sprouts powder alone or with triple therapy eradicated H. pylori in many type 2 diabetes patients and improved some cardiovascular risk factors.

Eighty-six patients with type 2 diabetes and positive H. pylori stool antigen tests were randomized to standard triple therapy (STT) for 14 days, 6 g/d broccoli sprouts powder (BSP) for 28 days, or both (STT + BSP). H. pylori eradication rates were 89.3% in STT, 56.0% in BSP, and 91.7% in STT + BSP. Systolic and diastolic blood pressure significantly decreased in the STT + BSP group (P < 0.05), while serum triglycerides and TG/HDL-C ratio increased in the STT group (<0.05). In the BSP-only group, serum hs-CRP significantly decreased from 3.0 ± 2.5 at baseline to 2.3 ± 2.1 after treatment (P < 0.05).

Mirmiran P, Bahadoran Z, Golzarand M, et al. J Diabetes Metab Disord, 2014. PMID 24940565

2012 / Randomized double-blind clinical trial

Broccoli sprouts powder may improve insulin resistance in type 2 diabetic patients.

Eighty-one type 2 diabetic patients were randomly assigned to receive 10 g/d broccoli sprouts powder (BSP), 5 g/d BSP, or placebo for 4 weeks, with 63 included in the analysis. After 4 weeks, consumption of 10 g/d BSP resulted in a significant decrease in serum insulin concentration and HOMA-IR (p = 0.05 for treatment effect). Fasting serum glucose and glucose-to-insulin ratio were also measured. The authors concluded that broccoli sprouts may improve insulin resistance in type 2 diabetic patients.

Bahadoran Z, Tohidi M, Nazeri P, et al. Int J Food Sci Nutr, 2012. PMID 22537070

2011 / Double-blind, placebo-controlled randomized clinical trial

Broccoli sprouts powder significantly reduced markers of oxidative stress and increased antioxidant capacity in patients with type 2 diabetes.

In a double-blind trial, 81 patients with type 2 diabetes were randomly assigned to receive 10 g/d broccoli sprouts powder (BSP), 5 g/d BSP, or placebo for 4 weeks, with 63 patients analyzed. Consumption of BSP resulted in a significant decrease in malondialdehyde (P=0.001), oxidized LDL cholesterol (P=0.03), and oxidative stress index (P=0.001), along with a significant increase in total antioxidant capacity (P=0.001). No significant effects were observed on total oxidant status.

Bahadoran Z, Mirmiran P, Hosseinpanah F, et al. Eur J Clin Nutr, 2011. PMID 21559038